Gene Therapy Company bluebird bio (BLUE) Files $86M IPO
Tweet Send to a Friend
Cambridge-based bluebird bio (Nasdaq: BLUE) filed a $86.25 million IPO Tuesday evening. The company plans to list on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


